|Morphine and alternative opioids in cancer pain: the EAPC recommendations|
GW Hanks, F De Conno, N Cherny, M Hanna, E Kalso, HJ McQuay, ...
British Journal of cancer 84 (5), 587, 2001
|Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC|
A Caraceni, G Hanks, S Kaasa, MI Bennett, C Brunelli, N Cherny, O Dale, ...
The lancet oncology 13 (2), e58-e68, 2012
|Malignant bone pain: pathophysiology and treatment|
Pain 69 (1-2), 1-18, 1997
|Strategies to manage the adverse effects of oral morphine: an evidence-based report|
N Cherny, C Ripamonti, J Pereira, C Davis, M Fallon, H McQuay, ...
Journal of Clinical Oncology 19 (9), 2542-2554, 2001
|Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care|
S Mercadante, L Radbruch, A Caraceni, N Cherny, S Kaasa, F Nauck, ...
Cancer 94 (3), 832-839, 2002
|Opioid rotation for cancer pain|
Cancer 86 (9), 1856-1866, 1999
|Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer|
C Ripamonti, R Twycross, M Baines, F Bozzetti, S Capri, F De Conno, ...
Supportive Care in Cancer 9 (4), 223-233, 2001
|Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study|
S Mercadante, A Casuccio, F Fulfaro, L Groff, R Boffi, P Villari, V Gebbia, ...
Journal of Clinical Oncology 19 (11), 2898-2904, 2001
|Opioid switching: a systematic and critical review|
S Mercadante, E Bruera
Cancer treatment reviews 32 (4), 304-315, 2006
|Anaemia in cancer: pathophysiology and treatment|
S Mercadante, V Gebbia, A Marrazzo, S Filosto
Cancer treatment reviews 26 (4), 303-311, 2000
|Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study|
S Mercadante, E Arcuri, W Tirelli, A Casuccio
Journal of pain and symptom management 20 (4), 246-252, 2000
|Current knowledge of buprenorphine and its unique pharmacological profile|
J Pergolizzi, AM Aloisi, A Dahan, J Filitz, R Langford, R Likar, ...
Pain Practice 10 (5), 428-450, 2010
|Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial|
C Ripamonti, S Mercadante, L Groff, E Zecca, F De Conno, A Casuccio
Journal of pain and symptom management 19 (1), 23-34, 2000
|Celiac plexus block versus analgesics in pancreatic cancer pain|
Pain 52 (2), 187-192, 1993
|Breakthrough pain in cancer patients: pathophysiology and treatment|
S Mercadante, E Arcuri
Cancer treatment reviews 24 (6), 425-432, 1998
|Pain treatment and outcomes for patients with advanced cancer who receive follow‐up care at home|
Cancer: Interdisciplinary International Journal of the American Cancer …, 1999
|The course of symptom frequency and intensity in advanced cancer patients followed at home|
S Mercadante, A Casuccio, F Fulfaro
Journal of pain and symptom management 20 (2), 104-112, 2000
|Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction|
S Mercadante, C Ripamonti, A Casuccio, E Zecca, L Groff
Supportive care in cancer 8 (3), 188-191, 2000
|A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial|
S Mercadante, L Radbruch, A Davies, P Poulain, T Sitte, P Perkins, ...
Current medical research and opinion 25 (11), 2805-2815, 2009
|Problems of long-term spinal opioid treatment in advanced cancer patients|
Pain 79 (1), 1-13, 1999